Add Some Rice To Your
Life
Advances in Rice-Based Products with
Potential Benefits to Health
By Raxit J. Jariwalla, Ph.D.
California Institute for Medical Research
San Jose, California 95128
The word '"fiber" comes to mind when we think
of cereals, whole grains
and health. However, while fiber is important to our
health, it is not
the sole ingredient endowed with medicinal value. Other
constituents
locked within cereals and grains possess important
physiologic and
pharmacologic properties which are being rapidly uncovered
by medical
research. This is best exemplified in the case of rice and
its
components, which was the focus of an international
symposium held last
summer in Kyoto, Japan.
Rice is an important staple cereal of a large fraction
of the world's
population. It is primarily consumed after processing as
polished
rice. The bran or germ which comprises 10% of whole rice
is removed
during the polishing process. However, rice bran is an
important source of
rice oil and other phytochemicals which possess
antioxidative and
disease-fighting properties. Traditionally, rice-bran
products have found
applications in agricultural, food and cosmetic
industries. Now, medical
research has unraveled scientific evidence supporting a
role for key
components of rice in health maintenance and disease
prevention.
Rice-based products drawing much attention of
biomedical researchers
include: myo-inositol (a B vitamin), its
phosphate-derivative inositol
hexaphosphate (IP6 or phytate), rice-bran oil and
polyphenols with
antioxidant function. IP6 is the major form of
phosphorylated inositol
present in foods, constituting 1-5% by weight of most
cereals, nuts,
oilseeds, legumes and grains. It occurs at 9.5-14.5% by
weight in rice
bran. Antioxidative polyphenols in rice bran include
ferulic acid, its
esterified derivatives (oryzanols), tocopherols and other
phenolic
compounds.
The first international symposium on "Disease
Prevention by IP6 and
Other Components of Rice" was held last June in
Kyoto. About 520
people convened at this conference devoted to inositol,
inositol
hexaphosphate and other components of rice. Some 20
speakers presented
papers on topics ranging from chemistry and mechanisms of
action to
anti-cancer effects and other beneficial functions of IP6.
About 10
studies were presented on ferulic acid, rice bran oil and
other
components of rice. In addition, 65 other papers were
presented in
poster sessions as reports of research which complemented
above studies.
From the quality of the information presented, it can
be said that
increased consumption of rice and its products would
result in improved
health, with reduction in heart disease, renal stones and
some forms of
cancer.
The symposium was sponsored by Tsuno Foods & Rice
which, since 1947, has been
developing and improving ways of using rice bran for
industrial manufacture
based on rice oil extraction and refinery. In fact, the
symposium was held at
the occasion of the company's 50th anniversary. Its
purpose was to foster
exchange of information and ideas about important
developments that have
bearing on disease prevention by rice components with
medicinal properties.
Back to Index
Beneficial Effects of IP6 and Inositol
The symposium started with a discussion of chemistry
and usage of rice
components. S. Ogawa (Keio University) presented an
impressive overview
of chemical structures and uses of myo-inositol and its
related
compounds. T. Osawa (Nagoya University) discussed the
protective role of rice
antioxidants in oxidative stress and Y. Watanabe (Ehime
University, Matsuyama)
reviewed the synthesis of inositol triphosphate and
phospholipids.
A large portion of the symposium was devoted to IP6 and
its parent
molecule, inositol. It is difficult to summarize all the
studies
presented at the conference. This article will touch upon
major
findings of relevance to disease prevention and treatment.
Back to Index
Cancer
Let's consider the advances against cancer. A renowned
epidemiologist
reviewed studies linking diet and life style to cancer (S.Sugano,
Cancer
Institute, Tokyo). It's been known for sometime that
consumption of whole
grains, vegetables and fruits is linked to reduced cancer
risk. These foods
are rich in fiber which has been shown to protect against
both colonic and
mammary cancer (reviewed by B.S. Reddy and L. A. Cohen,
American Health
Foundation, New York). However, as it became apparent at
the symposium, fiber
is not the sole anticarcinogen since other substances in
fiber-containing
foods also exert protective influences on cancer. Thus, a
multinational
epidemiologic study carried out in the mid 1980's had
shown that foods rich in
phytate (IP6) but poor in fiber, such as cereals and
grains, correlated better
with reduced risk of colon cancer than phytate-poor fiber
foods such as fruits
and vegetables (Graf and Eaton, Cancer 1985; 56:717-718).
IP6 is a strong
chelating agent and certain metals are known to promote
cancer through
generationof reactive free radicals from oxidation of
fats. IP6 also plays an
important role in regulating cell proliferation and
differentiation.
In 1988, the first two studies were published,
reporting inhibitory
effects of purified IP6 on tumor formation in experimental
animals. One
study (Shamsuddin et al. Carcinogenesis 9:577-80) showed
suppression of
cancer of the large bowel by IP6 and theother study (Jariwalla
et al.
Nutr. Res. 8: 813-27) demonstrated reduction of the
incidence and size
of soft-tissue tumors (fibrosarcomas) promoted by dietary
factors.
Since then, a number of experimental studies have
confirmed the
anti-cancer action of IP6 (reviewed by I. Vucenik and
A.K.M. Shamsuddin, Univ.
of Maryland, Baltimore). The compound has been shown to
inhibit various
rodent and human cancer cell lines in vitro and to protect
against growth of
diverse cancers in vivo. Protective effects have been seen
against cancers of
the breast, colon, pancreas, liver, skin and connective
tissue. In vivo,IP6
not only prevents carcinogen-induced tumor development but
it also interferes
with growth of pre-formed, transplanted tumors, suggesting
that it may play a
role in both cancer prevention and treatment.
The step at which IP6 acts during tumor development
varies depending
upon the type of cancer studied. In colon carcinogenesis,
IP6 was shown to
suppress bowel cancer when given before, during and even
several months after
carcinogen administration (Shamsuddin and colleagues,
Univ. of Maryland).In
a multi-organ rat carcinogenesis model, IP6 administered
(as phytic acid)
during the promotion stage suppressed hepatic tumors but
had no influence on
development of esophagal, colonic, pancreatic, renal and
thyroid tumor lesions
(M. Hirose, National Institute of Health Sciences, Tokyo).
In a
two-stage model of carcinogenesis in mouse skin, IP6
inhibited tumor
formation when given during the initiation stage but not
during tumor
promotion, indicating differential sensitivity of skin
cancer (T. Ishikawa,
Univ. of Tokyo). Clinical studies in humans against
different tumor types
would be useful. Awaiting such studies,
what can be said presently is that naturally-occurring
salt forms of IP6
appear to be safe in animal studies even when used at
higher than
physiologic dosages.
The role of myo-inositol as a chemopreventive agent was
also discussed.
It is another phytochemical with low toxicity and ability
to inhibit
carcinogenesis in various organs which include mammary
gland, colon and
lung. In studies evaluating its chemopreventive activity
in lung
carcinogenesis (L. W. Wattenberg, Univ. of Minneapolis,
Minnesota), it
was reported that myo-inositol has unusual properties,
manifesting a
capacity to prevent lung cancer when given during separate
phases of the
carcinogenic process as well as throughout the entire
course of the process.
When administered throughout the carcinogenic process,
it's effects were found
to be additive. Another study reported on suppression of
liver cancer by oral
administration of myo-inositol, thus adding to the diverse
spectrum of tumors
affected by this naturally-derived plant constituent (H.
Nishino, Kyoto Prefectual
University of Medicine). Myo-inositol has also been
reported to enhance the
anti-cancer action of IP6 in other animal studies.
Back to Index
Mechanism of Cancer Suppression
The mechanism by which IP6 or myo-inositol exert
chemopreventive and
anti-cancer effects is not completely understood. IP6 is
rapidly
absorbed by cells (in vitro and in vivo) and metabolized
to lower
phosphates and inositol (reviewed by Shamsuddin). It has
been suggested
that lower inositol phosphates may mediate cancer
inhibition, although
direct evidence for this is lacking. Both IP6 and its
lower phosphates have
metal chelating activity and may interfere with tumor
formation by suppressing
metal catalyzed oxidation of fats. Alternatively, IP6 may
block the activity
of key enzyme(s) affecting cell proliferation. One enzyme
candidate is PI-3
kinase which plays a central role in signal transduction
and cell
transformation triggered by growth factor or tumor
promoter. IP6 has been
reported to inhibit PI-3 kinase activity in vitro (Z.
Dong, Univ. of
Minnesota, Austin). While this enzyme inhibition may
explain the
chemopreventive effect of IP6, it is not known whether it
mediates IP6's
effect on pre-existing tumors or
established cancer cells. Other, as yet, unknown mechanism
may be
involved in the anti-cancer effect of IP6.
Back to Index
Heart Disease
The ability of IP6 to reduce hyperlipidemia and protect
against
cardiovascular disease (CVD) was also discussed. CVD is
associated with high
mortality in Western and other industrialized countries.
It is linked to
several risk factors among which is hyperlipidemia -- high
levels of
cholesterol and triglycerides in blood.
It has been known that consumption of Bengal gram, a
bean species rich
in IP6, is associated with reduced hypercholesterolemia.
In one study,
which directly addressed the role of IP6 in hyperlipidemia,
it was shown that
IP6-supplemented diet lowered total cholesterol and
triglycerides levels in
serum of animals made hyperlipemic with a high cholesterol
diet (reviewed by
R. J. Jariwalla, Calif. Institute for Medical Research,
San Jose). The same
study demonstrated that dietary IP6 caused a lowering of
the zinc/copper
ratio, a marker of hypercholesterolemia, without
significantly affecting
levels of other minerals in serum. This lipid-lowering
action of IP6 was seen
at dosages (upto 9% of the diet) that were free of adverse
side effects in the
tested animals.
Another study reported on the hypolipidemic action of
myo-inositol and
IP6 relevant to treatment of fatty liver (T. Katayama,
Hiroshima Univ.). At
physiologic dosages (0.1 -0.5% of diet), these compounds
inhibit rises in
hepatic total lipids andtriglycerides resulting from
administration of sucrose. The mechanism of this
hypolipidemic effect in the
liver appears to be related to the inhibition of hepatic
enzymes involved in
lipogenesis rather than inhibition of intestinal enzymes.
Although
physiological levels of IP6 depress accumulation of
lipids, they have little
effect on elevated serum lipids. Indeed, these dietary
treatments (upto 2.5%
IP6) do not produce significant changes in hepatic
cholesterol or serum total
lipid levels in sucrose-treated animals, consistent with
findings from the
above study showing reduction of serum hyperlipidemia at
higher supplementary
levels of dietary IP6.
IP6 and its derivatives also manifest other benficial
effects relevant
to CVD. In separate reports, IP6 was shown to inhibit
platelet
aggregation (I. Vucenik, Univ. of Maryland, Baltimore) and
to enhance
inflammatory responses of neutrophils in response to
microbial stimuli
(P. Eggleton, Oxford Univ.). In earlier animal studies,
lower inositol
phosphates have been shown to inhibit calcification in the
aorta and
lipid peroxidation in ischemic kidneys, consistent with a
role for
hydrolysates of IP6 in protecting against hardening of the
arteries
(reviewed by R. J. Jariwalla).
Back to Index
Kidney Stones
Epidemiologic studies have shown that renal stones are
more prevalent in
developed countries where populations consume diets based
on refined
flour compared to those in developing nations consuming
predominantly a
phytate-rich diet. IP6 is naturally present in human urine
where normal
levels fluctuate between 0.5 to 5.0 mg/liter (F. Grases,
Univ. of Balearic
Islands, Spain). Approximately 1-3% of oral doses are
excreted in the urine
with an associated reduced risk of developing renal
stones. Biochemical
studies have shown that phytate
can interfere with formation of calculi (crystals) of
calcium oxalate
and phosphate (reviewed by F. Grases). This has been
demonstrated in
vitro in a system that resembles calculi formation in the
kidney as well as in
an animal model of nephrolithiasis where crystal/stone
formation and
calcifications on renal papillary tissue are induced by
ethylene glycol. In a
preliminary clinical study of 30 renal stone-formers,
ingestion of 120mg/day
of IP6 was demonstrated to reduce the urinary risk of
kidney stone
development.
Back to Index
Role in Transmission of Chemical Messages
A portion of the symposium was devoted to the role of
IP6 and inositol
in signal transduction, the pathway for transmission of
external
messages to the interior of cells. Inositol phopholipids
present in
plasma membranes have drawn much attention because of
their role as
intermediaries in transmission of signals elicited by
growth factors and
mitogens acting at the cell surface. Since inositol occurs
ubiquitously in
cell membranes in conjugation with lipids as
phosphatidylinositol, it plays a
critical role in this process. Additionally, IP6 is the
only known dietary
source of inositol phospholipids. During cell stimulation,
these molecules
are converted by special enzymes (PI kinases and
phospholipase C) to inositol
triphosphate (IP3) and diacylglycerol which act as second
messengers inside
cells (reviewed by G. Weber, Univ. of Indiana,
Indianapolis). IP3 also plays
a role in cell-to-cell communication and can be generated
from IP6 via a
salvage pathway.
In one report (by G. Weber), the activity of signal-transduction
enzymes and
concentration of IP3 were reported to be elevated in
several types of tumors
above those in normal cells. Anti-tumor componds such as
genistein and
quercetin act by inhibiting PI kinases and lowering IP3
concentration in tumor
cells leading to cellular differentiation and death. A
nuclear
inositol-lipid pathway was also described with signal-transduction
components
located and acting in the nucleus (L. Cocco, Univ. of
Bologna, Italy). This
signalling pathway appears to be important in switching
cell programming from
a proliferative to a differentiative state. Finally, it
was
reported that IP6 is the dominant inositol phosphate in
insulin-secreting cells of the pancreas where it
influences secretion of the
hormone by modulating activity of a calcium channel (P.O.
Berggren,Karolinska
Institute, Stockholm).
Back to Index
Beneficial Effects of Other Rice Components
Much attention was devoted during the latter third of
the symposium to
other components of rice that include rice germ (or bran),
antioxidative
polyphenols and rice bran oil. Polyphenols from edible
plants are a rich
source of antioxidative compounds with chemopreventive
activity (N.Nakatani,
Osaka City Univ.).There was much discussion of ferulic
acid (from rice grain)
and its esterified derivatives, gamma-oryzanol and
cycloartenyl ferulate.
Ferulic acid is a ubiquitous polyphenol that is formed
from metabolism
of two amino acids (phenylalanine and tyrosine), occurring
primarily in
the bran fraction of plant seeds (H. Taniguchi, Industrial
Technology
Center of Wakayama Prefecture). Natural ferulic acid is
commercially
extracted and purified from rice bran oil for which a
cost-effective
manufacturing process has been developed by Tsuno Foods.
The compound
has strong antioxidant potential, protecting skin cells
from light or
radiation-induced damage and preserving foods from
spoilage due to lipid
peroxidation. Photoprotection of skin cells has potential
utility for
dermatologic applications. The antioxidative function may
also play a
protective role in inflammatory diseases and other
industrial applications of
ferulic acid.
Evidence was discussed for a chemopreventive role of
rice germ, ferulic
acid and its derivatives. In animal studies (presented by
G. Mori, Gifu
Univ.) rice germ showed a chemopreventive effect in large
bowel
carcinogenesis. Ferulic acid inhibits liver carcinogenesis
and was shown to
reduce development of oral lesions induced by chemical
carcinogen (G. Mori).
EGMP, a synthetic derivative of ferulic acid has a
modifying effect on rat
colon carcinogenesis (H. Tsuda, National Cancer Center
Research Institute,
Tokyo). Other ferulate derivatives prevented and dissolved
platelet
aggregation related to thrombosis (H. Kayahara, Shinshu
Univ.). An ester of
DL-alpha tocopherol (vitamin E) and ferulic acid prevented
facial
hyperpigmentation by suppressing melanogenesis induced by
UV light (M.
Ichihashi, Kobe Univ.).
Several papers were devoted to the benefits of rice
bran oil (reviewed
by M. Sugano, Kumamoto Univ.). Known as a healthy oil, it
is rich in
polyunsaturated fatty acids, lowers blood lipid levels and
has a role in
preventing hardening of the arteries. In animals fed a
high-fat and
cholesterol diet, rice bran oil suppressed the development
of
hyper-cholesterolemia and lowered the atherogenic index.
In combination with
safflower oil (7 parts to 3), it exhibits a blending
effect, yielding greater
reduction of serum cholesterol than either oil alone. This
effect appears to
be due to a unique balance of individual fatty acids and
the presence of
non-fatty acid components.
Rice bran oil is rich in non-saponifiable matters such
as steryl
ferulates which have growth-promoting vitamin like
activity. They
consist of a mixture of ferulic acid esters called
oryzanols, of which
gamma-oryzanol is the best characterized and studied (H.
Naruse,
Kyokuto International Co., Ltd., Tokyo). It is used
commercially in Japan as
a food and as a medical antioxidant in combination with
alpha-tocopherol
(vitamin E). It protects rice bran oil from oxidation and
inhibits
peroxidation of lipids mediated by iron or UV irradiation.
Its triterpene
alcohol components, cycloartenyl and
24-methylene-cycloartenyl ferulates are
effective in the treatment of arteriosclerosis.
Cycloartenol magnified the
cholesterol-lowering
effect of plant sterols and in combination with beta-sitosterol
produced an
increased lowering of plasma and liver cholesterol (M.
Sugano). In the
two-stage carcinogenesis model in mouse skin, cycloartenol
ferulate inhibited
tumor promotion, indicating also a role in the
chemoprevention of cancer
(K.Yasukawa et al., Nihon Univ.).
The future looks very promising for rice-based
constituents as a source
of functional foods as new components with beneficial
health functions
are isolated and identified. The impression that
participants derived
after a two-day exposure to rice science was that everyone
should
increase their consumption of rice or rice bran, a rich
source of
phytochemicals with striking medicinal properties.
Back to Index
Back
to Top